The PRESERVE Trial is the first large-scale, multi-specialty, prospective clinical study to evaluate the use of inferior vena cava (IVC) filters and related follow-up treatment in the United States.
It is sponsored by IVC Filter Study Group Foundation, which is a joint collaboration between the Society of Interventional Radiology (SIR) and the Society for Vascular Surgery (SVS).
As of August 2018, four manufacturers have reached their 300 filter patient enrollment cap.
Important information about PRESERVE.
617.923.7747 Email Us
Funding for this trial provided by the IVC Filter Study Group Foundation
Privacy | Site Map